| Faripour A Forouhar, MD | |
|
263 Farmington Ave, Anatomic Pathology, Farmington, CT 06030-0001 | |
| (860) 679-2980 | |
| (860) 679-4334 |
| Full Name | Faripour A Forouhar |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 53 Years |
| Location | 263 Farmington Ave, Farmington, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366448656 | NPI | - | NPPES |
| 1201250 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 020125 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| John Dempsey Hospital | Farmington, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Connecticut Health Center | 3678472016 | 523 |
News Archive
The American Academy of Child and Adolescent Psychiatry (AACAP) is pleased to announce David A. Axelson, M.D, Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine, and Western Psychiatric Institute and Clinic, and Director, Child and Adolescent Bipolar Services, Western Psychiatric Institute and Clinic, as the recipient of the Klingenstein Third Generation Foundation Award for Research in Depression or Suicide for his paper, "Course of Subthreshold Bipolar Disorder in Youth: Diagnostic Progression From Bipolar Disorder Not Otherwise Specified," published in the October 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
Alexandria, Va., USA - Parach Sirivichayakul, Mahidol University, Bangkok, Thailand, presented the poster "Preventing Approximal Caries in Primary Teeth With Topical Fluorides" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021.
› Verified 1 days ago
| Entity Name | University Of Connecticut Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720083769 PECOS PAC ID: 3678472016 Enrollment ID: O20040106000105 |
News Archive
The American Academy of Child and Adolescent Psychiatry (AACAP) is pleased to announce David A. Axelson, M.D, Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine, and Western Psychiatric Institute and Clinic, and Director, Child and Adolescent Bipolar Services, Western Psychiatric Institute and Clinic, as the recipient of the Klingenstein Third Generation Foundation Award for Research in Depression or Suicide for his paper, "Course of Subthreshold Bipolar Disorder in Youth: Diagnostic Progression From Bipolar Disorder Not Otherwise Specified," published in the October 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
Alexandria, Va., USA - Parach Sirivichayakul, Mahidol University, Bangkok, Thailand, presented the poster "Preventing Approximal Caries in Primary Teeth With Topical Fluorides" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Faripour A Forouhar, MD 263 Farmington Ave, Provider Enrollment, Farmington, CT 06030-2212 Ph: (860) 679-7503 | Faripour A Forouhar, MD 263 Farmington Ave, Anatomic Pathology, Farmington, CT 06030-0001 Ph: (860) 679-2980 |
News Archive
The American Academy of Child and Adolescent Psychiatry (AACAP) is pleased to announce David A. Axelson, M.D, Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine, and Western Psychiatric Institute and Clinic, and Director, Child and Adolescent Bipolar Services, Western Psychiatric Institute and Clinic, as the recipient of the Klingenstein Third Generation Foundation Award for Research in Depression or Suicide for his paper, "Course of Subthreshold Bipolar Disorder in Youth: Diagnostic Progression From Bipolar Disorder Not Otherwise Specified," published in the October 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.
A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.
Targeted alpha therapy has the potential to selectively eliminate HIV infected cells from the central nervous system, according to a recent study co-authored by the JRC. The study shows that a specific human antibody labelled with the alpha emitter bismuth-213 can penetrate the blood brain barrier and selectively target and destroy HIV-infected cells while sparing non-infected healthy cells.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
Alexandria, Va., USA - Parach Sirivichayakul, Mahidol University, Bangkok, Thailand, presented the poster "Preventing Approximal Caries in Primary Teeth With Topical Fluorides" at the virtual 99th General Session & Exhibition of the International Association for Dental Research (IADR), held in conjunction with the 50th Annual Meeting of the American Association for Dental Research (AADR) and the 45th Annual Meeting of the Canadian Association for Dental Research (CADR), on July 21-24, 2021.
› Verified 1 days ago
Dr. Maryam J Zenali, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Dr. Christopher Alan Wallace, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 270 Farmington Avenue, Suite 332, Farmington, CT 06089 Phone: 888-276-2223 Fax: 972-767-0225 | |
Dollett Tanisha White, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 11 Shuttle Rd, Farmington, CT 06032 Phone: 860-679-3980 | |
Esma Ersoy, MD Pathology Medicare: Medicare Enrolled Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Margaret Grunnet, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 | |
Christina Stanley, Pathology Medicare: Not Enrolled in Medicare Practice Location: 11 Shuttle Rd, Farmington, CT 06032 Phone: 860-679-1076 | |
Qian Wu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 263 Farmington Ave, Farmington, CT 06030 Phone: 860-679-2980 Fax: 860-679-4334 |